StockData

TFA Therapeutics, Inc. (RAJAF) income statement

RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on May 15, 2026Score 7/30
$9.18+0.00 (0.00%)

Close on Oct 16, 2026Market cap –P/E –Yield –

TFA Therapeutics, Inc. income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin
61.1%
Operating margin
-11.3%
Net margin
-12.4%
Return on equity, FY2025
34.0%

Financial strength

Current ratio
0.19
Debt to equity
–
Debt to assets
–
Cash to current liabilities
0.1%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?